{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:13:47Z","timestamp":1788272027009,"version":"build-2803163510"},"reference-count":71,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UH3 AI 133675-PI Grov"],"award-info":[{"award-number":["UH3 AI 133675-PI Grov"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI 124414"],"award-info":[{"award-number":["P30 AI 124414"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01 AA 029047"],"award-info":[{"award-number":["K01 AA 029047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["AIDS Care"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/09540121.2026.2649875","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:41:16Z","timestamp":1779972076000},"page":"2023-2034","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["How low-income gay and bisexual men who have sex with men navigate financial challenges to HIV pre-exposure prophylaxis use: a qualitative study"],"prefix":"10.1080","volume":"38","author":[{"given":"Jacob","family":"Bleasdale","sequence":"first","affiliation":[{"name":"University of Florida","place":["Gainesville, USA"]},{"name":"University of Florida"},{"name":"University of Central Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"D'Angelo","sequence":"additional","affiliation":[{"name":"City University of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige E.","family":"Murrill","sequence":"additional","affiliation":[{"name":"University of Florida","place":["Gainesville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin","family":"Cohen","sequence":"additional","affiliation":[{"name":"City University of New York"},{"name":"City University of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Nash","sequence":"additional","affiliation":[{"name":"City University of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Grov","sequence":"additional","affiliation":[{"name":"City University of New York"},{"name":"City University of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew A.","family":"Westmoreland","sequence":"additional","affiliation":[{"name":"University of Florida","place":["Gainesville, USA"]},{"name":"University of Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"AIDSVu. (2024). AIDSVu releases new PrEP data and launches PrEPVu.org a new PrEP equity platform. June 25 2024. Retrieved August 10 2025 from: https:\/\/aidsvu.org\/news-updates\/aidsvu-releases-new-prep-data-and-launches-prepvu-org-a-new-prep-equity-platform\/."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13382"},{"key":"e_1_3_3_4_1","unstructured":"American Psychological Association. (2025). Update on cuts to medicaid funding and restrictions to medicaid access. July 16 2025. Retrieved August 11 2025 from https:\/\/updates.apaservices.org\/update-on-proposed-cuts-to-medicaid-funding."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004006"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172354"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03624-6"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-024-04366-3"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1037\/13620-004"},{"key":"e_1_3_3_11_1","unstructured":"California Department of Public Health. (n.d.). PrEP 2-1-1: \u201cOn-demand\u201d pre-exposure prophylaxis (PrEP) for sexual intercourse."},{"key":"e_1_3_3_12_1","unstructured":"Centers for Disease Control and Prevention. (2023). Preliminary Data on pre-exposure prophylaxis coverage released. Retrieved July 5 2024 from: https:\/\/www.cdc.gov\/hiv\/policies\/dear-colleague\/dcl\/20231017.html."},{"key":"e_1_3_3_13_1","unstructured":"Centers for Disease Control and Prevention. (2025a). Clinical guidance for PrEP. Retrieved July 18 2025 from https:\/\/www.cdc.gov\/hivnexus\/hcp\/prep\/index.html."},{"key":"e_1_3_3_14_1","unstructured":"Centers for Disease Control and Prevention. (2025b). HIV diagnoses deaths and prevalence: 2025 update. Retrieved April 29 2025 from https:\/\/www.cdc.gov\/hiv-data\/nhss\/hiv-diagnoses-deaths-and-prevalence-2025.html."},{"key":"e_1_3_3_15_1","unstructured":"Centers for Medicare & Medicaid Services. (2024). Social drivers of health and health-related social needs. 2024 February 27 2025. Retrieved June 21 2025 from https:\/\/www.cms.gov\/priorities\/innovation\/key-concepts\/social-drivers-health-and-health-related-social-needs."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines2010129"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2025.00037"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/tbm\/ibz191"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2023.00808"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/0033354918801353"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/2325958219848848"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2018.1557590"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2014.0303"},{"key":"e_1_3_3_24_1","unstructured":"Gilead Sciences. (2025a). Gilead advancing access. Retrieved July 11 2025 from https:\/\/prep.advancingaccess.com\/orals."},{"key":"e_1_3_3_25_1","unstructured":"Gilead Sciences. (2025b). Yeztugo\u00ae (Lenacapavir) is now the first and only FDA-approved HIV prevention option offering 6 months of protection. 2025 June 18 2025. Retrieved July 15 2025 from https:\/\/www.gilead.com\/news\/news-details\/2025\/yeztugo-lenacapavir-is-now-the-first-and-only-fda-approved-hiv-prevention-option-offering-6-months-of-protection."},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002954"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2012.0419"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70847-3"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2019.05.003"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2023.00867"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-024-04306-1"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00079-6"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2022.2029816"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2019.0150"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/00333549231208487"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2023.0158"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2024.0113"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01295-0"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506273"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30089-9"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157742"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.2196\/13715"},{"key":"e_1_3_3_44_1","unstructured":"National Alliance of State & Territorial AIDS Directors. (2024). National PrEP\/PEP Assistance Program Directory. Retrieved July 30 2025 from https:\/\/nastad.org\/sites\/default\/files\/2024-10\/PDF-PrEP-PEP-AP-Detailed-Table.pdf."},{"key":"e_1_3_3_45_1","unstructured":"National Alliance of State & Territorial AIDS Directors. (n.d.). State PrEP\/PEP Assistance Programs. Retrieved July 11 2025 from https:\/\/nastad.org\/prepcost-resources\/state-prep-assistance-programs."},{"key":"e_1_3_3_46_1","unstructured":"NYC Department of Health and Mental Hygiene. (n.d.). \u201cOn-Demand\u201d Dosing for PrEP: Guidance for medical providers."},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.2196\/12405"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000004124"},{"key":"e_1_3_3_50_1","unstructured":"Patient Advocate Foundation. (n.d.). HIV AIDS and Prevention. Retrieved July 11 2025 from https:\/\/copays.org\/funds\/hiv-aids-and-prevention\/."},{"key":"e_1_3_3_51_1","unstructured":"Ringel J. S. et al. (2002). The elasticity of demand for health care: a review of the literature and its application to the military health system."},{"key":"e_1_3_3_52_1","unstructured":"San Francisco Department of Public Health. (2019). Important HIV Prevention and Treatment Updates for San Francisco Providers."},{"key":"e_1_3_3_53_1","unstructured":"Silverman E. (2024). Gilead plans to halt free access to an HIV drug worrying patient advocates. STAT."},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/09564624221132406"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2022.306793"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2024.89654"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(25)00036-0"},{"key":"e_1_3_3_58_1","unstructured":"The AIDS Institute. (2025). Fact Sheet: Cutting Medicaid Threatens Plans to End the HIV Epidemic. February 2025. Retrieved August 10 2025 from https:\/\/www.theaidsinstitute.org\/RRA\/fact-sheet-cutting-medicaid-threatens-plans-to-end-the-hiv-epidemic."},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-019-00430-z"},{"key":"e_1_3_3_60_1","unstructured":"U.S. Department of Agriculture Economic Research Service. (2012). U.S. Household Food Security Survey Module: Three-Stage Design with Screeners."},{"key":"e_1_3_3_61_1","unstructured":"U.S. Department of Health and Human Services. (2020). Healthy People 2030 \u2014 Social Determinants of Health. 2020. Retrieved June 21 2025 from https:\/\/odphp.health.gov\/healthypeople\/priority-areas\/social-determinants-health."},{"key":"e_1_3_3_62_1","unstructured":"U.S. Department of Health and Human Services. (2021). FAQS ABOUT AFFORDABLE CARE ACT IMPLEMENTATION PART 47. Retrieved July 4 2025 from https:\/\/www.cms.gov\/CCIIO\/Resources\/Fact-Sheets-and-FAQs\/Downloads\/FAQs-Part-47.pdf."},{"key":"e_1_3_3_63_1","unstructured":"U.S. Department of Health and Human Services. (2024). Patient Assistance Programs and Co-payment Assistance Programs: Resources for Accessing PrEP. 2024 March 24 2024. Retrieved July 11 2025 from https:\/\/www.hiv.gov\/hiv-basics\/hiv-prevention\/using-hiv-medication-to-reduce-risk\/pre-exposure-prophylaxis\/accessing."},{"key":"e_1_3_3_64_1","unstructured":"U.S. Department of Health and Human Services. (2025a). How Can I Pay for PrEP? July 9 2025. Retrieved July 11 2025 from: https:\/\/files.hiv.gov\/s3fs-public\/2024-06\/PrEP-LogicModel.pdf."},{"key":"e_1_3_3_65_1","unstructured":"U.S. Department of Health and Human Services. (2025b). Ready Set PrEP Program Information. Retrieved July 30 2025 from https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/prep-program."},{"key":"e_1_3_3_66_1","unstructured":"U.S. Department of Health and Human Services. (n.d.). READY SET PrEP."},{"key":"e_1_3_3_67_1","unstructured":"U.S. Food and Drug Administration. (2021). FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention. 2021 December 20 2021 [cited 2023 October 1]; https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention."},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-024-00714-z"},{"key":"e_1_3_3_69_1","unstructured":"Viiv Healthcare. (2025). ViiVConnect. March 2025; Retrieved from https:\/\/www.viivconnect.com\/patient\/get-savings-information\/apretude\/."},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.5042"},{"key":"e_1_3_3_71_1","unstructured":"Weir M. (2025). Congressional Proposals to Change Medicaid Threaten the HIV Response. May 14 2025 [cited 2025 August 10]."},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(22)00030-3"}],"container-title":["AIDS Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09540121.2026.2649875","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/09540121.2026.2649875","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09540121.2026.2649875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:19:06Z","timestamp":1788268746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09540121.2026.2649875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/09540121.2026.2649875"],"URL":"https:\/\/doi.org\/10.1080\/09540121.2026.2649875","relation":{},"ISSN":["0954-0121","1360-0451"],"issn-type":[{"value":"0954-0121","type":"print"},{"value":"1360-0451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=caic20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=caic20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}